DE69109557T2 - Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm. - Google Patents

Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.

Info

Publication number
DE69109557T2
DE69109557T2 DE69109557T DE69109557T DE69109557T2 DE 69109557 T2 DE69109557 T2 DE 69109557T2 DE 69109557 T DE69109557 T DE 69109557T DE 69109557 T DE69109557 T DE 69109557T DE 69109557 T2 DE69109557 T2 DE 69109557T2
Authority
DE
Germany
Prior art keywords
administration
possibility
large intestine
solid drug
drug form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69109557T
Other languages
English (en)
Other versions
DE69109557D1 (de
Inventor
Fujio Sekigawa
Yoshiro Onda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Chemical Co Ltd
Original Assignee
Shin Etsu Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Chemical Co Ltd filed Critical Shin Etsu Chemical Co Ltd
Application granted granted Critical
Publication of DE69109557D1 publication Critical patent/DE69109557D1/de
Publication of DE69109557T2 publication Critical patent/DE69109557T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE69109557T 1990-07-10 1991-07-05 Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm. Expired - Fee Related DE69109557T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2182157A JP2773959B2 (ja) 1990-07-10 1990-07-10 大腸内放出性固形製剤

Publications (2)

Publication Number Publication Date
DE69109557D1 DE69109557D1 (de) 1995-06-14
DE69109557T2 true DE69109557T2 (de) 1995-09-28

Family

ID=16113355

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69109557T Expired - Fee Related DE69109557T2 (de) 1990-07-10 1991-07-05 Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.

Country Status (8)

Country Link
US (1) US5217720A (de)
EP (1) EP0466566B1 (de)
JP (1) JP2773959B2 (de)
KR (1) KR960006063B1 (de)
CN (1) CN1037933C (de)
AU (1) AU633220B2 (de)
CA (1) CA2046739C (de)
DE (1) DE69109557T2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
US10799460B2 (en) 2011-09-07 2020-10-13 Roland SAUR-BROSCH Formulation for the controlled release of one or several substances in the digestive tract of a mammal

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
DK0616802T3 (da) * 1992-08-13 1998-10-19 Teikoku Seiyaku Kk Oralt præparat til frigivelse i de nedre fordøjelseskanaler
US5356634A (en) * 1992-11-13 1994-10-18 Eastman Chemical Company Controlled-release delivery system
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
WO1997027843A2 (en) * 1996-01-30 1997-08-07 Advanced Polymer Systems, Inc. Targeted delivery of drugs to the lower gastrointestinal tract
AU3481497A (en) * 1996-06-11 1998-01-07 Zonagen, Inc. Chitosan drug delivery system
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6248362B1 (en) * 1997-03-26 2001-06-19 Meiji Seika Kaisha, Ltd. Large intestinal delivery composite
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6638534B1 (en) 1998-07-28 2003-10-28 Tanabe Seiyaku Co., Ltd. Preparation capable of releasing drug at target site in intestine
CA2376261A1 (en) 1999-06-09 2000-12-14 Mochida Pharmaceutical Co., Ltd. System for release in lower gastrointestinal tract
WO2001010467A1 (fr) * 1999-08-09 2001-02-15 Dainippon Pharmaceutical Co., Ltd. Preparations solides contenant de la poudre de chitosane et procede de production associe
JP4524009B2 (ja) * 1999-08-09 2010-08-11 大日本住友製薬株式会社 大腸内放出性カプセル製剤
BR0013720A (pt) 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Formulação em pelota de liberação controlada
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
CA2412776C (en) * 2000-06-16 2011-03-15 Mitsubishi Pharma Corporation Compositions controlling release ph range and/or speed
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
KR100404769B1 (ko) * 2001-01-31 2003-11-10 주식회사 비에스텍 팬에 부착된 향 송풍장치
KR20040047747A (ko) * 2001-03-13 2004-06-05 펜웨스트 파머슈티칼즈 컴파니 변시치료 제형
KR100413114B1 (ko) * 2001-03-30 2003-12-31 재단법인서울대학교산학협력재단 키토산으로 표면 코팅된 조직 재생용 생분해성 고분자제제 및 그 제조방법
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
DE102004040243A1 (de) * 2003-08-22 2005-03-17 Heppe, Katja, Dipl.-Biotechnol. Transportsystem auf Chitosanbasis
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
CA2539051C (en) * 2003-09-19 2014-08-12 Penwest Pharmaceuticals Co. Delayed release dosage forms
EP1718621A4 (de) 2004-01-30 2009-08-19 Univ Johns Hopkins Nitroxylvorläuferverbindungen anwendungsverfahren
EP1727525A4 (de) * 2004-03-23 2009-12-09 Lytone Enterprise Inc In chitosan eingebettete oder verkapselte kapsel
RU2375047C2 (ru) * 2004-03-26 2009-12-10 Лек Фармасьютиклз Д.Д. Фармацевтическая лекарственная форма, устойчивая к действию желудочного сока, включающая n-(2-(2-фталимидоэтокси)ацетил)-l-аланил-d-глутаминовую кислоту (lk 423)
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
EP2803357B1 (de) 2004-06-25 2020-11-18 The Johns-Hopkins University Angiogenesehemmer
US8912214B2 (en) * 2005-07-29 2014-12-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of Chk2 kinase inhibitors for cancer treatment
BRPI0615972A2 (pt) 2005-07-29 2011-05-31 Concert Pharmaceuticals Inc composto isolado, mistura, composição, item de manufatura, uso de um composto, método para determinar a concentração do composto em uma amostra biológica, kit de diagnóstico e método para avaliar a estabilidade metabólica de um composto
WO2007109175A1 (en) 2006-03-17 2007-09-27 Johns Hopkins University School Of Medicine N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
JP5386176B2 (ja) * 2006-12-21 2014-01-15 フロイント産業株式会社 キトサン溶液及び該溶液から形成されたキトサンコーティング製剤
US8551995B2 (en) 2007-01-19 2013-10-08 Xcovery Holding Company, Llc Kinase inhibitor compounds
KR101905004B1 (ko) 2007-09-26 2018-10-08 존스 홉킨스 유니버시티 신규의 생리적으로 유용한 니트록실 도너로서 ｎ-히드록실술폰아미드 유도체
KR101115501B1 (ko) * 2007-11-30 2012-02-27 주식회사 키토라이프 시플로플록사신이 담지된 저분자량 수용성 키토산 미립자에고분자가 코팅된 다중입자 및 이의 제조방법
EP3067352A3 (de) 2008-05-07 2016-10-19 Cardioxyl Pharmaceuticals Inc. Neuartige nitrosoverbindungen als nitroxyldonatoren und verfahren zur verwendung davon
EP2303018B1 (de) 2008-06-19 2015-10-14 Xcovery Holding Company LLC Substituierte pyridazincarboxamidverbindungen als kinasehemmerverbindungen
US8729097B2 (en) 2008-10-06 2014-05-20 The Johns Hopkins University Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disorders
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
AU2010328234B2 (en) * 2009-12-07 2016-05-12 Cardioxyl Pharmaceuticals, Inc. N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivatives
US9018411B2 (en) * 2009-12-07 2015-04-28 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
CA2813607C (en) 2010-10-08 2021-08-31 Xcovery Holding Company, Llc Substituted pyridazine carboxamide compounds
JP6177246B2 (ja) 2011-10-17 2017-08-09 ザ・ジョンズ・ホプキンス・ユニバーシティ ヒドロキシルアミンで置換された、ｈｎｏ供与体としてのメルドラム酸、バルビツール酸、及びピラゾロンの誘導体
JP6306602B2 (ja) 2012-11-01 2018-04-04 ザ ジョンズ ホプキンス ユニバーシティ 分子内環化−脱離による制御されたｈｎｏ放出
JP5836980B2 (ja) 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
JP6449171B2 (ja) 2013-01-18 2019-01-09 カルディオキシル ファーマシューティカルズ，インク． 治療指数の改善されたニトロキシル供与体
EP2983702A2 (de) 2013-04-07 2016-02-17 The Broad Institute, Inc. Zusammensetzungen und verfahren für personalisierte neoplasieimpfstoffe
US10801070B2 (en) 2013-11-25 2020-10-13 The Broad Institute, Inc. Compositions and methods for diagnosing, evaluating and treating cancer
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
BR112016014410A2 (pt) 2013-12-20 2018-02-20 The Broad Institute Inc. terapia de combinação com vacina de neoantígeno
ES2734060T3 (es) 2014-01-17 2019-12-04 Cardioxyl Pharmaceuticals Inc Donadores de nitroxilo de N-hidroximetanosulfonamida
US9682938B2 (en) 2014-05-27 2017-06-20 Cardioxyl Pharmaceuticals, Inc. Pyrazolone derivatives as nitroxyl donors
EP3148983A1 (de) 2014-05-27 2017-04-05 The Johns Hopkins University N-hydroxylaminobarbitursäure-derivate als nitroxyldonatoren
US9464061B2 (en) 2014-05-27 2016-10-11 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives
JP6435179B2 (ja) * 2014-12-08 2018-12-05 フロイント産業株式会社 大腸ドラッグデリバリーシステム錠剤
EP3234193B1 (de) 2014-12-19 2020-07-15 Massachusetts Institute of Technology Molekulare biomarker für krebsimmuntherapie
US10993997B2 (en) 2014-12-19 2021-05-04 The Broad Institute, Inc. Methods for profiling the t cell repertoire
AU2015369903B2 (en) 2014-12-23 2020-07-02 Cerecor, Inc. Compounds, compositions and methods
MY190974A (en) 2015-05-20 2022-05-25 Massachusetts Gen Hospital Shared neoantigens
AU2016276783B2 (en) 2015-06-09 2020-07-02 Rexahn Pharmaceuticals, Inc. Fluorocyclopentenylcytosine uses and processes of preparation
CN108025009A (zh) 2015-09-04 2018-05-11 瑞恩药品公司 喹喔啉基-哌嗪酰胺的使用方法
AU2017254477A1 (en) 2016-04-18 2018-11-01 Jennifer G. ABELIN Improved HLA epitope prediction
USRE49834E1 (en) 2016-10-03 2024-02-13 Hangzhou Highlightll Pharmaceutical Co., Ltd. Jak1 selective inhibitors and uses thereof
EP3574116A1 (de) 2017-01-24 2019-12-04 The Broad Institute, Inc. Zusammensetzungen und verfahren zum nachweis einer mutanten variante eines polynukleotids
RU2020136057A (ru) 2018-05-04 2022-05-04 Толлиз Лиганды tlr3, которые активируют как эпителиальные, так и миелоидные клетки
WO2020072700A1 (en) 2018-10-02 2020-04-09 Dana-Farber Cancer Institute, Inc. Hla single allele lines
WO2020131586A2 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Methods for identifying neoantigens
US20220202818A1 (en) 2019-04-18 2022-06-30 The Regents Of The University Of Michigan Combination with checkpoint inhibitors to treat cancer
JP2022530314A (ja) * 2019-04-30 2022-06-29 ディーエスエム アイピー アセッツ ビー．ブイ． 特定の水溶性ビタミンのための新規な送達システム
KR20220003039A (ko) * 2019-04-30 2022-01-07 디에스엠 아이피 어셋츠 비.브이. 지용성 비타민에 대한 새로운 전달 시스템
EP4158014A2 (de) 2020-05-26 2023-04-05 Dionis Therapeutics, Inc. Bibliotheken künstlicher mini-proteome aus nukleinsäuren
US20240050415A1 (en) 2020-06-05 2024-02-15 Henry Ford Health System Daclatasvir for use in treating lung and prostate cancer
CN117295716A (zh) 2020-12-22 2023-12-26 麦克尼斯迪克治疗有限公司 作为egfr和/或pi3k抑制剂的取代氨基苄基杂芳基化合物
WO2022189861A1 (en) 2021-03-08 2022-09-15 Tollys Carbohydrate conjugates of tlr3 ligands and uses thereof
CN117897156A (zh) 2021-08-10 2024-04-16 贝达药业股份有限公司 恩沙替尼或其盐在治疗携带met 14外显子跳跃突变的疾病中的用途
WO2023076733A1 (en) 2021-11-01 2023-05-04 Dana-Farber Cancer Institute, Inc. Biologically selected nucleic acid artificial mini-proteome libraries
CN115192537B (zh) * 2022-07-27 2024-03-26 康普药业股份有限公司 一种甲磺酸萘莫司他组合物及其制备方法
CN117426267A (zh) * 2023-12-21 2024-01-23 山东科赛基农生物工程有限公司 水稻生产全程健康管理方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
BR8506634A (pt) * 1984-12-20 1986-09-09 Rhone Poulenc Sante Composicoes para o revestimento de aditivos alimentares destinados aos ruminantes e granulados sob forma de microcapsulas assim revestidos
FR2582909B1 (fr) * 1985-06-07 1991-05-10 Aec Chim Organ Biolog Produit pour l'alimentation des ruminants et sa preparation.
JPH02107060A (ja) * 1988-10-17 1990-04-19 Matsushita Electric Ind Co Ltd 画信号処理方法
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
JPH0813748B2 (ja) * 1990-04-23 1996-02-14 帝國製薬株式会社 大腸崩壊性ポリペプチド系経口製剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
US10799460B2 (en) 2011-09-07 2020-10-13 Roland SAUR-BROSCH Formulation for the controlled release of one or several substances in the digestive tract of a mammal

Also Published As

Publication number Publication date
AU8027291A (en) 1992-01-16
CN1037933C (zh) 1998-04-08
JP2773959B2 (ja) 1998-07-09
AU633220B2 (en) 1993-01-21
KR920002135A (ko) 1992-02-28
CN1058904A (zh) 1992-02-26
JPH0469333A (ja) 1992-03-04
EP0466566B1 (de) 1995-05-10
DE69109557D1 (de) 1995-06-14
EP0466566A3 (en) 1992-12-09
CA2046739C (en) 2000-02-29
CA2046739A1 (en) 1992-01-11
KR960006063B1 (ko) 1996-05-08
EP0466566A2 (de) 1992-01-15
US5217720A (en) 1993-06-08

Similar Documents

Publication Publication Date Title
DE69109557T2 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
DE3688532T2 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
DE3882848D1 (de) Kosmetikbasiszubereitung mit arzneimitteleigenschaften.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
DE69115229T2 (de) Arzneimittel.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69224941T2 (de) Arzneimittelabgabekatheter
DE69101931T2 (de) Pharmazeutische Zusammensetzung.
DE69427472T2 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DE3884237D1 (de) Beschichtete Kunststoffolie und daraus hergestelltes Kunststofflaminat.
DE69133445D1 (de) Arzneistoffabgabesystem
DE3782840D1 (de) Arzneimittel mit verzoegerter freigabe.
FI911652A0 (fi) Farmaceutisk beredning av nitroglycering foer perkutan administration.
DE3879111D1 (de) Pharmazeutische kautablette mit geschmaksmaskierung.
NO911429L (no) Stoffbehandling.
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
MX9200532A (es) Agente farmaceuticos.
NO911430D0 (no) Stoffbehandlingsmetode.
FI923371A0 (fi) En farmaceutisk formulation.
IT8722218A0 (it) Ftalazino derivati ad attivita'farmaceutica.
BR9206343A (pt) Agente atrativo e estimulante de ingestão para baratas.
NO942228D0 (no) Ipsapiron-legemiddeltilberedning
IT8820618A0 (it) Forma farmaceutica e supporto per la somministrazione di estratti ellergenici.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee